Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.
The Oklahoman: NBA star Russell Westbrook adds pharmaceutical startup to growing investments in OKC
Westbrook, who played for the Oklahoma City Thunder for several years, has made multiple investments in the city since leaving the team.